CTBP2 and acute respiratory distress syndrome: Consequently, we hypothesized that blocking CtBP2-p300-NF-κB using their respective inhibitors would mitigate LPS-driven proinflammatory cytokine gene expression, thereby potentially ameliorating the in vivo symptoms in ARDS mice.